IGF2 and prostate carcinoma: Therefore, in diverse human cancers, like Wilm's tumour41and prostate cancer,42 the increase in IGF2 caused by LOI has been studied a lot.43 However, the abnormal expression of miR‐483‐3p and IGF2 has not been reported in HSCR.